SEMPRA Net Income (Loss) Available to Common Stockholders, Diluted
SEMPRA (SRE) reported Net Income (Loss) Available to Common Stockholders, Diluted of $1.80 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-02-26
- SEMPRA net income (loss) available to common stockholders, diluted for the quarter ending 2021-12-31 was $604.00M, a 45.89% increase year-over-year.
- SEMPRA net income (loss) available to common stockholders, diluted for the quarter ending 2021-09-30 was -$648.00M, a 284.62% decline year-over-year.
- SEMPRA net income (loss) available to common stockholders, diluted for the quarter ending 2021-06-30 was $424.00M, a 81.06% decline year-over-year.
- SEMPRA net income (loss) available to common stockholders, diluted for the quarter ending 2021-03-31 was $884.00M, a 11.06% increase year-over-year.
- SEMPRA net income (loss) available to common stockholders, diluted for fiscal 2025 was $1.80B, a 36.24% decline from fiscal 2024.
- SEMPRA net income (loss) available to common stockholders, diluted for fiscal 2024 was $2.82B, a 7.03% decline from fiscal 2023.
- SEMPRA net income (loss) available to common stockholders, diluted for fiscal 2023 was $3.03B, a 44.70% increase from fiscal 2022.
- SEMPRA net income (loss) available to common stockholders, diluted for fiscal 2022 was $2.09B, a 66.99% increase from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.80B 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $2.82B 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $3.03B 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $2.09B 10-K · filed 2025-02-25 | |||
| 2021-12-31 | $604.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$44.00M derived: sum of 2 quarters · filed 2024-02-27 | $380.00M derived: sum of 3 quarters · filed 2024-02-27 | $1.25B 10-K · filed 2024-02-27 |
| 2021-09-30 | -$648.00M 10-Q · filed 2021-11-05 | -$224.00M derived: sum of 2 quarters · filed 2021-11-05 | $650.00M 10-Q · filed 2021-11-05 | $1.07B derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $424.00M 10-Q · filed 2021-08-05 | $1.30B 10-Q · filed 2021-08-05 | $1.72B derived: sum of 3 quarters · filed 2023-02-28 | $2.07B derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $884.00M 10-Q · filed 2021-05-05 | $1.30B derived: sum of 2 quarters · filed 2023-02-28 | $1.65B derived: sum of 3 quarters · filed 2023-02-28 | $3.89B derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $414.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $765.00M derived: sum of 2 quarters · filed 2023-02-28 | $3.00B derived: sum of 3 quarters · filed 2023-02-28 | $3.76B 10-K · filed 2023-02-28 |
| 2020-09-30 | $351.00M 10-Q · filed 2021-11-05 | $2.59B derived: sum of 2 quarters · filed 2021-11-05 | $3.35B 10-Q · filed 2021-11-05 | $3.83B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $2.24B 10-Q · filed 2021-08-05 | $3.05B 10-Q · filed 2021-08-05 | $3.48B derived: sum of 3 quarters · filed 2022-02-25 | $4.32B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $796.00M 10-Q · filed 2021-05-05 | $1.24B derived: sum of 2 quarters · filed 2022-02-25 | $2.08B derived: sum of 3 quarters · filed 2022-02-25 | $2.44B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $447.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.29B derived: sum of 2 quarters · filed 2022-02-25 | $1.64B derived: sum of 3 quarters · filed 2022-02-25 | $2.06B 10-K · filed 2022-02-25 |
| 2019-09-30 | $839.00M 10-Q · filed 2020-11-05 | $1.19B derived: sum of 2 quarters · filed 2020-11-05 | $1.61B 10-Q · filed 2020-11-05 | $2.50B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $354.00M 10-Q · filed 2020-08-05 | $795.00M 10-Q · filed 2020-08-05 | $1.66B derived: sum of 3 quarters · filed 2021-02-25 | $1.93B derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $441.00M 10-Q · filed 2020-05-04 | $1.30B derived: sum of 2 quarters · filed 2021-02-25 | $1.58B derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | $864.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.14B derived: sum of 2 quarters · filed 2021-02-25 | $924.00M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $274.00M 10-Q · filed 2019-11-01 | $60.00M 10-Q · filed 2019-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UGI CORP /PA/ (UGI) | United States | $7.803B | 11.04 |
| Montauk Renewables, Inc. (MNTK) | United States | $0.409B | 28.00 |
| Clean Energy Fuels Corp. (CLNE) | United States | $0.364B | |
| OPAL Fuels Inc. (OPAL) | United States | $0.046B | 5.62 |